Medicinal Herbs for Hepatitis C Virus Infection: A Cochrane Hepatobiliary Systematic Review of Randomized Trials

  title={Medicinal Herbs for Hepatitis C Virus Infection: A Cochrane Hepatobiliary Systematic Review of Randomized Trials},
  author={Jianpin Liu and Eric W. Manheimer and Kiichiro Tsutani and Christian Gluud},
  journal={American Journal of Gastroenterology},
OBJECTIVE:The aim of this study was to assess beneficial and harmful effects of medicinal herbs for hepatitis C virus (HCV) infection.METHODS:The databases of the Cochrane Collaboration, MEDLINE, EMBASE, and BIOSIS were searched combined with manual searches of five Chinese and one Japanese journals. We included randomized trials comparing medicinal herbs with placebo, no intervention, nonspecific treatment, other herbs, or interferon and/or ribavirin. Trials of herbs with or without other drug… 

Figures and Tables from this paper

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C

The challenges identified and addressed during development of this United States multicenter Phase II trial to evaluate silymarin for treatment of patients with chronic hepatitis C infection who had failed to respond successfully to previous IFN-based therapy are common and must be addressed to conduct rigorous trials of botanical products.

Silymarin treatment of viral hepatitis: a systematic review

Silymarin compounds likely decrease serum transaminases in patients with chronic viral hepatitis, but do not appear to affect viral load or liver histology, and it may be worthwhile to determine its effects in conjunction with standard antiviral treatment.

Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

Higher than customary doses of silymarin did not significantly reduce serum ALT levels more than placebo in participants with chronic HCV infection unsuccessfully treated with interferon-based therapy.

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results.

  • M. TanamlyF. Tadros G. Strickland
  • Medicine
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2004

Study of Hepatoprotective Effect of Silymarin and Ursodeoxycholic Acid in Chronic Hepatitis C Patients

A statistically significant improvement in mean serum levels of ALT, AST, and bilirubin was obtained with UDCA therapy either when administered alone or combined with silymarin, however, sily marin treatment failed to significantly affect liver function tests.

Hepatitis C therapies: A chronology of Past, Present and Future Strategies

Keeping in view the genotype of HCV, viral load and virologic response to treatment, pegylated interferon alpha in combination with ribavirin soon became the standard of care for treating hepatitis C.

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.

Oxymatrine capsule is effective and safe in treatment of hepatic fibrosis due to chronic viral hepatitis and the rate of adverse events was similar in two groups.

Complementary and alternative medications in hepatitis C infection.

Many of the natural molecules that interact with the hepatitis C virus (HCV) life cycle are reviewed and discussed and their potential use and safety in HCV therapy, as well as some important interactions between medical and complementary treatments are highlighted.

Prevalence and Predictors of Herbal Medication Use in Veterans with Chronic Hepatitis C

The use of herbal preparations is prevalent among veterans with chronic hepatitis C, especially those with higher levels of education and higher incomes.

Evaluation of serum aminotransaminases and bilirubin in different treatment regimens for chronic hepatitis C virus

Serum ALT is a normal value after all treatment regimens included in this study while serum AST is slightly elevated in combination therapy of pegylated interferon plus ribavirin while serum bilirubin is highly elevated in case of sofosbuvir dual therapy than sofOSbuvir trible therapy.



Medicinal herbs for hepatitis C virus infection.

None of the medicinal herbs showed positive effects on clearance of serum HCV RNA or anti-HCV antibody or on serum liver enzymes, except one short-term trial in which a silybin preparation showed a significant effect on reducing serum aspartate aminotransferase and gamma-glutamyltranspeptidase activities.

Preliminary report of a randomized, double‐blind placebo‐controlled trial of a Chinese herbal medicine preparation CH‐100 in the treatment of chronic hepatitis C

The treatment of chronic hepatitis C is relatively unsatisfactory and many patients have turned to unproven alternative medicines to modify the course of their illness. We report a study of a Chinese

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials

Treatment with interferon alfa plus ribavirin has a significant beneficial effect on the virological and histological responses of patients with chronic hepatitis C, irrespective of previous treatment.

Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.

The combined therapy with ursodeoxycholic acid and glycyrrhizin is safe and effective in improving liver-specific enzyme abnormalities, and may be an alternative to interferon in chronic hepatitis C virus infection, especially for interferons-resistant or unstable patients.

Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.

Combination therapy increased the number of naive patients, relapsers, and non-responders with a sustained virological, biochemical, or histological response, but also the occurrence of adverse events.

Preliminary study on therapeutic effect of oxymatrine in treating patients with chronic hepatitis C

  • Ji-qiang LiChaoqun Li Guo-qin Li
  • Medicine, Biology
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
  • 1998
Oxymatrine is effective in inhibiting proliferation of HCV, antagonisting liver fibrosis and regulating immune reaction of the host, so it could be a safe, effective drug in treating chronic hepatitis C.

Effect of Gansu Capsule on Chronic Hepatitis C

It is indicated that GC can increase the effect of interferon on chronic hepatitis C and reduce its relapse.

Oral Thymic Extract for Chronic Hepatitis C in Patients Previously Treated with Interferon

A randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Complete Thymic Formula in patients with chronic HCV infection who did not respond to or were intolerant of interferon monotherapy.

Clinical Investigation on Treatment of Chronic Hepatitis C with Compound Chinese Medicine Bingganning

Bingganning has similar good effect in the treatment of chronic hepatitis C.